ORIC Pharmaceuticals, Inc. (ORIC) Misses Q3 EPS by 1c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• Klarna (KLAR) Reiterated at Market Perform by Citizens Amid Volume Headwinds
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance